Federal Register / Vol. 80, No. 18 / Wednesday, January 28, 2015 / Notices 4593 

Controlled substance Schedule 

4-Anilino-N-phenethyl-4-piperidine 

(8333).

II 

Phenylacetone (8501) .................. II 

Cocaine (9041) ............................. II 

Opium, raw (9600) ....................... II 

Poppy Straw Concentrate (9670) II 

The company plans to import the 

listed controlled substances for internal 

use, and to manufacture bulk 

intermediates for sale to its customers. 

Dated: January 21, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–01587 Filed 1–27–15; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Registration: Research Triangle 

Institute 

ACTION: Notice of registration. 

SUMMARY: Research Triangle Institute 

applied to be registered as an importer 

of a certain basic class of narcotic 

controlled substance. The DEA grants 

Research Triangle Institute registration 

as an importer of this controlled 

substance. 

SUPPLEMENTARY INFORMATION: By notice 

dated April 21, 2014, and published in 

the Federal Register on April 28, 2014, 

79 FR 23373, Research Triangle 

Institute, Kenneth S. Rehder, Ph.D., 

Hermann Building, East Institute Drive, 

P.O. Box 12194, Research Triangle Park, 

North Carolina 27709, applied to be 

registered as an importer of a certain 

basic class of narcotic controlled 

substance. No comments or objections 

were submitted for this notice. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823, 952(a) and 

958(a) and determined that the 

registration of Research Triangle 

Institute to import the basic class of 

controlled substance is consistent with 

the public interest and with United 

States obligations under international 

treaties, conventions, or protocols in 

effect on May 1, 1971. The DEA 

investigated the company’s maintenance 

of effective controls against diversion by 

inspecting and testing the company’s 

physical security systems, verifying the 

company’s compliance with state and 

local laws, and reviewing the company’s 

background and history. 

Therefore, pursuant to 21 U.S.C. 

952(a) and 958(a), and in accordance 

with 21 CFR 1301.34, the above-named 

company is granted registration as an 

importer of noroxymorphone (9668), a 

basic class of narcotic controlled 

substance listed in schedule II. 

The company plans to import small 

quantities of the listed controlled 

substance for the National Institute on 

Drug Abuse for research activities. 

Dated: January 21, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–01578 Filed 1–27–15; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Bulk Manufacturer of Controlled 

Substances Application: Rhodes 

Technologies 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration in 

accordance with 21 CFR 1301.33(a) on 

or before March 30, 2015. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. Request for hearings should be 

sent to: Drug Enforcement 

Administration, Attention: Hearing 

Clerk/LJ, 8701 Morrissette Drive, 

Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Deputy Assistant 

Administrator of the DEA Office of 

Diversion Control (‘‘Deputy Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.33(a), this is notice that on March 

13, 2014, Rhodes Technologies, 498 

Washington Street, Coventry, Rhode 

Island 02816, applied to be registered as 

a bulk manufacturer of the following 

basic classes of controlled substances: 

Controlled substance Schedule 

Tetrahydrocannabinols (7370) ..... I 

Methylphenidate (1724) ................ II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Hydrocodone (9193) ..................... II 

Levorphanol (9220) ...................... II 

Morphine (9300) ........................... II 

Oripavine (9330) ........................... II 

Thebaine (9333) ........................... II 

Oxymorphone (9652) ................... II 

Noroxymorphone (9668) .............. II 

Tapentadol (9780) ........................ II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

the listed controlled substances in bulk 

for conversion and sale to dosage form 

manufacturers. 

In reference to drug code 7370 the 

company plans to bulk manufacture a 

synthetic tetrahydrocannabinol. No 

other activity for this drug code is 

authorized for this registration. 

Dated: January 21, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–01598 Filed 1–27–15; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Manufacturer of Controlled 

Substances Registration: Johnson 

Matthey, Inc. 

ACTION: Notice of registration. 

SUMMARY: Johnson Matthey, Inc. applied 

to be registered as a manufacturer of 

certain basic classes of controlled 

substances. The DEA grants Johnson 

Matthey, Inc. registration as a 

manufacturer of those controlled 

substances. 

SUPPLEMENTARY INFORMATION: By notice 

dated September 25, 2014, and 

published in the Federal Register on 

October 7, 2014, 79 FR 60498, Johnson 

Matthey, Inc., Custom Pharmaceuticals 

Department, 2003 Nolte Drive, West 

Deptford, New Jersey 08066–1742, 

applied to be registered as a 

manufacturer of a certain basic class of 

controlled substance. No comments or 

objections were submitted to this notice. 

mstockstill on DSK4VPTVN1PROD with NOTICES